Verve Therapeutics Statistics
Total Valuation
ADX:AFNIC has a market cap or net worth of AED 279.51 million. The enterprise value is 93.45 million.
Market Cap | 279.51M |
Enterprise Value | 93.45M |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ADX:AFNIC has 1.33 million shares outstanding. The number of shares has increased by 0.01% in one year.
Current Share Class | 1.33M |
Shares Outstanding | 1.33M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 41,128 |
Valuation Ratios
The trailing PE ratio is 5.76.
PE Ratio | 5.76 |
Forward PE | n/a |
PS Ratio | 0.46 |
PB Ratio | 0.81 |
P/TBV Ratio | 0.81 |
P/FCF Ratio | 1.60 |
P/OCF Ratio | 1.58 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.44, with an EV/FCF ratio of 0.54.
EV / Earnings | 1.93 |
EV / Sales | 0.15 |
EV / EBITDA | 1.44 |
EV / EBIT | 1.88 |
EV / FCF | 0.54 |
Financial Position
The company has a current ratio of 81.00, with a Debt / Equity ratio of 0.05.
Current Ratio | 81.00 |
Quick Ratio | 48.65 |
Debt / Equity | 0.05 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.10 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.52% and return on invested capital (ROIC) is 8.69%.
Return on Equity (ROE) | 14.52% |
Return on Assets (ROA) | 3.65% |
Return on Invested Capital (ROIC) | 8.69% |
Return on Capital Employed (ROCE) | 5.44% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.72 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ADX:AFNIC has paid 3.97 million in taxes.
Income Tax | 3.97M |
Effective Tax Rate | 7.56% |
Stock Price Statistics
Beta (5Y) | 0.01 |
52-Week Price Change | n/a |
50-Day Moving Average | 210.00 |
200-Day Moving Average | 210.00 |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADX:AFNIC had revenue of AED 612.02 million and earned 48.50 million in profits. Earnings per share was 36.44.
Revenue | 612.02M |
Gross Profit | 57.37M |
Operating Income | 49.65M |
Pretax Income | 52.47M |
Net Income | 48.50M |
EBITDA | 52.64M |
EBIT | 49.65M |
Earnings Per Share (EPS) | 36.44 |
Balance Sheet
The company has 204.23 million in cash and 18.17 million in debt, giving a net cash position of 186.06 million or 139.79 per share.
Cash & Cash Equivalents | 204.23M |
Total Debt | 18.17M |
Net Cash | 186.06M |
Net Cash Per Share | 139.79 |
Equity (Book Value) | 345.03M |
Book Value Per Share | 259.14 |
Working Capital | 364.66M |
Cash Flow
In the last 12 months, operating cash flow was 177.11 million and capital expenditures -2.68 million, giving a free cash flow of 174.42 million.
Operating Cash Flow | 177.11M |
Capital Expenditures | -2.68M |
Free Cash Flow | 174.42M |
FCF Per Share | 131.05 |
Margins
Gross margin is 9.37%, with operating and profit margins of 8.11% and 7.92%.
Gross Margin | 9.37% |
Operating Margin | 8.11% |
Pretax Margin | 8.57% |
Profit Margin | 7.92% |
EBITDA Margin | 8.60% |
EBIT Margin | 8.11% |
FCF Margin | 28.50% |
Dividends & Yields
ADX:AFNIC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | n/a |
Earnings Yield | 17.35% |
FCF Yield | 62.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on April 29, 2021. It was a forward split with a ratio of 1.1.
Last Split Date | Apr 29, 2021 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |